derinet® Switzerland
Back

8.50% p.a. Barrier Reverse Convertible on BioNTech, Johnson & Johnson, Merck, Moderna, Pfizer (Quanto CHF)

  • Valor 111765601
  • ISIN CH1117656012
  • Symbol RMCG9V
Bid (indicative)%
Nominal
Ask (indicative)%
Nominal
CurrencyCHF
Price on
Sell
Buy
  • Quanto
  • (Issuer) Callable
Johnson & JohnsonUSD 
Merck & Co. Inc.USD 
Pfizer Inc.USD 
Moderna Inc.USD 
BioNTech SEUSD 
Please note that this is an indication.

Documents

Key data
Yield max.93.99%
Yield max. p.a.44.75%
Barrier reachedno
Interest
Coupon (Coupon p.a.)17.00% (8.50%)
Premium component17.0000%
Interest share0.00%
Day count convention30/360
Pricingdirty
Life cycle
Initial fixing27/10/2021
First Trading Day29/10/2021
Payment date01/11/2021
Final fixing27/10/2023
Redemption03/11/2023

Current price information

Intraday1 week1 monthyear to dateSince emission
until
Product Underlying

Loading data

Performance
UnderlyingClosing PriceStrike PriceBarrier
USD 169.23USD 278.77USD 125.45
USD 167.10USD 163.74USD 73.68
USD 81.54USD 81.54USD 36.69
USD 186.61USD 340.88USD 153.40
USD 54.11USD 42.97USD 19.34

No chart available

Key data
Yield max.93.99%
Yield max. p.a.44.75%
Barrier reachedno
Interest
Coupon (Coupon p.a.)17.00% (8.50%)
Premium component17.0000%
Interest share0.00%
Day count convention30/360
Pricingdirty
Life cycle
Initial fixing27/10/2021
First Trading Day29/10/2021
Payment date01/11/2021
Final fixing27/10/2023
Redemption03/11/2023
Figures
SSPA categorisationBarriere Reverse Convertible
Issue price100.00%
Nominal valueCHF 1,000.00
Reference currencyCHF
QuantoYes
Strike price

Reference price of the underlying used to calculate the cash settlement on expiry of the warrant. In cases of physical delivery it is the price at which the underlying is bought (call) or sold (put). Also called: exercise price

100.00%
Barrier45.00%
Barrier observationcontinuous
ListingSIX Structured Products Exchange
Additional conditions
IssuerBank Vontobel AG, Zurich
Lead ManagerBank Vontobel AG, Zurich
Redemption / deliverycash payment
Issuance ProgrammeLink to the Issuance Program